http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Amarantus Amends LymPro LP-002 Clinical Protocol to Report Interim Data at #C4CT Presentation
-
Registration for the 3rd Alzheimer's-Focused #C4CT Summit Has Closed Due to Overwhelming Interest
-
Sidney Rice and Ben Utecht Talk to NFL Network's Andrea Kremer and ESPN's Andrew Brandt at Upcoming #C4CT Concussion Awareness Summit at the United Nations
-
Amarantus Appoints Donald D. Huffman to Board of Directors
-
Amarantus and BSI Announce Dr. Thomas Arendt as Presenter at 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations
-
Amarantus and BSI Proudly Announce BIO CEO & President Jim Greenwood as Panelist for 3rd Alzheimer's Focused #C4CT Concussion Awareness Summit at United Nations
-
Amarantus Discusses New Independent Peer-Reviewed Research Papers on MANF
-
Amarantus and BSI Announce Continued Support of One Mind at the 3rd #C4CT Concussion Awareness Summit at the United Nations
-
Amarantus Announces Positive Clinical Performance and 7-Year Longitudinal Data Poster Presentations for LymPro Test (R) at AAIC 2014
-
Amarantus Announces Positive Analytical Performance Data Poster Presentation for LymPro Test (R) at AAIC 2014
-
Amarantus' CEO to Host Twitter Chat on Thursday, July 10, 2014 at 4pm EDT
-
Amarantus and Brewer Sports Announce #C4CT Summit Morning Keynote Presentation by Congressman Chaka Fattah
-
Amarantus to Present at the 2014 BIO International Convention
-
Amarantus Enters Into Wolfram's Research Collaboration With Washington University School of Medicine
-
Amarantus and Brewer Sports Add Partnership With Cavendish Global to #C4CT Alzheimer's Concussion Awareness Summit at United Nations
-
Amarantus to Present at LD Micro Invitational on June 4th
-
Amarantus Reports First Quarter 2014 Financial Results
-
Amarantus to Present at the 15th Annual B. Riley & Co. Investor Conference
-
Amarantus Establishes Office in Geneva, Switzerland
-
Amarantus Acquires Additional Rights to LymPro Test From Memory Dx
-
Amarantus Announces Positive Independent Peer-Reviewed Preclinical Data for MANF in Alzheimer's and Diabetes
-
Cavendish Selects Amarantus to Present at the Cavendish Global Health Impact Forum
-
Amarantus Closes Warrant Solicitation; Enters Into $20 Million Purchase Agreement With Lincoln Park Capital Fund, LLC
-
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity
-
Amarantus Outlines MANF Research Collaboration Strategy
-
Amarantus Strengthens Management Team With Key Additions in Business Development and Regulatory Affairs
-
Amarantus Bioscience Holdings Announces $3M Solicitation of Previously Issued Warrants
-
Amarantus to Present at 16th Annual BIO CEO & Investor Conference
-
Amarantus Establishes LymPro Research Collaboration With Boston University School of Medicine
-
ESPN's Andrew Brandt Final Addition to #C4CT Concussion Awareness Summit
-
Clinton Portis, Jeremy Shockey, Dr. Robert Stern and NFL Network's Andrea Kremer Join #C4CT Concussion Awareness Summit at the United Nations During Super Bowl Week
-
Amarantus Founders Gerald and Dr. John Commissiong Selected as Black Money's "50 Most Important African-Americans in Technology"
-
Amarantus In-Licenses Levadopa-Induced Dyskinesia Phase 2b-Ready Eltoprazine From PGI Drug Discovery
-
Gerald Commissiong, CEO of Amarantus to Participate in Twitter Chat, "The Human Brain"
-
Amarantus to Present at Biotech and Healthcare Conferences During JP Morgan Week in San Francisco
-
Amarantus Licenses MANF-Related Wolfram's and Diabetes Therapeutic and Diagnostic Intellectual Property From University of Massachusetts Medical School
-
Amarantus and Brewer Sports Announce ONE MIND for Research at 2nd #C4CT Concussion Awareness Summit Prior to Super Bowl XLVIII at United Nations

